{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:30:37Z","timestamp":1777465837717,"version":"3.51.4"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"grant from Chinese Society of Blood Purification Administration","award":["CHABP2016-07"],"award-info":[{"award-number":["CHABP2016-07"]}]},{"name":"Chinese Society of Nephrology grant","award":["13030310416"],"award-info":[{"award-number":["13030310416"]}]},{"name":"Special Supporting Program for Young Teachers in Kunming Medical University"},{"name":"grant from Graduate Innovation Fund in Kunming Medical University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1007\/s11255-018-1993-8","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T14:00:31Z","timestamp":1538402431000},"page":"2061-2066","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Serum endocan and circadian heart rate variability in non-dialysis stage 5 chronic kidney disease patients"],"prefix":"10.1007","volume":"50","author":[{"given":"Yu","family":"Bao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-An","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hua","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng-Xian","family":"Pi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Yue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-Hua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-Ting","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-Kui","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4424-3691","authenticated-orcid":false,"given":"Xing-Wei","family":"Zhe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,10,1]]},"reference":[{"issue":"9818","key":"1993_CR1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S0140-6736(12)60033-6","volume":"379","author":"L Zhang","year":"2012","unstructured":"Zhang L et al (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet 379(9818):815\u2013822","journal-title":"Lancet"},{"issue":"Suppl 1","key":"1993_CR2","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/j.1755-6686.2010.00171.x","volume":"36","author":"RN Foley","year":"2010","unstructured":"Foley RN (2010) Clinical epidemiology of cardiovascular disease in chronic kidney disease. J Ren Care 36(Suppl 1):4\u20138","journal-title":"J Ren Care"},{"issue":"13","key":"1993_CR3","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1056\/NEJMoa041031","volume":"351","author":"AS Go","year":"2004","unstructured":"Go AS et al (2004) Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351(13):1296\u20131305","journal-title":"N Engl J Med"},{"issue":"6","key":"1993_CR4","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1001\/archinte.164.6.659","volume":"164","author":"DS Keith","year":"2004","unstructured":"Keith DS et al (2004) Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 164(6):659\u2013663","journal-title":"Arch Intern Med"},{"issue":"6","key":"1993_CR5","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1016\/j.numecd.2017.04.004","volume":"27","author":"D Aune","year":"2017","unstructured":"Aune D et al (2017) Resting heart rate and the risk of cardiovascular disease, total cancer, and all-cause mortality: a systematic review and dose-response meta-analysis of prospective studies. Nutr Metab Cardiovasc Dis 27(6):504\u2013517","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"10","key":"1993_CR6","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1093\/eurheartj\/ehi235","volume":"26","author":"P Palatini","year":"2005","unstructured":"Palatini P (2005) Heart rate: a strong predictor of mortality in subjects with coronary artery disease. Eur Heart J 26(10):943\u2013945","journal-title":"Eur Heart J"},{"issue":"8","key":"1993_CR7","doi-asserted-by":"publisher","first-page":"2482","DOI":"10.1093\/ndt\/gfp057","volume":"24","author":"S Beddhu","year":"2009","unstructured":"Beddhu S et al (2009) Associations of resting heart rate with insulin resistance, cardiovascular events and mortality in chronic kidney disease. Nephrol Dial Transplant 24(8):2482\u20132488","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"1993_CR8","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/01.HYP.33.1.44","volume":"33","author":"A Benetos","year":"1999","unstructured":"Benetos A et al (1999) Influence of heart rate on mortality in a French population: role of age, gender, and blood pressure. Hypertension 33(1):44\u201352","journal-title":"Hypertension"},{"issue":"6","key":"1993_CR9","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1177\/2047487312452501","volume":"21","author":"M Woodward","year":"2014","unstructured":"Woodward M et al (2014) The association between resting heart rate, cardiovascular disease and mortality: evidence from 112,680 men and women in 12 cohorts. Eur J Prev Cardiol 21(6):719\u2013726","journal-title":"Eur J Prev Cardiol"},{"issue":"11","key":"1993_CR10","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1097\/HJH.0b013e328330a938","volume":"27","author":"K Eguchi","year":"2009","unstructured":"Eguchi K et al (2009) Nocturnal nondipping of heart rate predicts cardiovascular events in hypertensive patients. J Hypertens 27(11):2265\u20132270","journal-title":"J Hypertens"},{"issue":"2","key":"1993_CR11","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.atherosclerosis.2011.03.037","volume":"217","author":"L Garcia-Ortiz","year":"2011","unstructured":"Garcia-Ortiz L et al (2011) Relationships of night\/day heart rate ratio with carotid intima media thickness and markers of arterial stiffness. Atherosclerosis 217(2):420\u2013426","journal-title":"Atherosclerosis"},{"issue":"1","key":"1993_CR12","first-page":"25","volume":"1765","author":"S Sarrazin","year":"2006","unstructured":"Sarrazin S et al (2006) Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta 1765(1):25\u201337","journal-title":"Biochim Biophys Acta"},{"issue":"6","key":"1993_CR13","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1038\/ki.2014.227","volume":"86","author":"MI Yilmaz","year":"2014","unstructured":"Yilmaz MI et al (2014) Plasma endocan levels associate with inflammation, vascular abnormalities, cardiovascular events, and survival in chronic kidney disease. Kidney Int 86(6):1213\u20131220","journal-title":"Kidney Int"},{"issue":"6","key":"1993_CR14","doi-asserted-by":"publisher","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","volume":"130","author":"AS Levey","year":"1999","unstructured":"Levey AS et al (1999) A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 130(6):461\u2013470","journal-title":"Ann Intern Med"},{"issue":"5 Suppl 3","key":"1993_CR15","doi-asserted-by":"publisher","first-page":"S112","DOI":"10.1053\/ajkd.1998.v32.pm9820470","volume":"32","author":"RN Foley","year":"1998","unstructured":"Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32(5 Suppl 3):S112\u2013S119","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1993_CR16","first-page":"441","volume":"92","author":"D Tousoulis","year":"2006","unstructured":"Tousoulis D, Charakida M, Stefanadis C (2006) Endothelial function and inflammation in coronary artery disease. Heart 92(4):441\u2013444","journal-title":"Heart"},{"issue":"4 Suppl 2","key":"1993_CR17","doi-asserted-by":"publisher","first-page":"S61","DOI":"10.1681\/ASN.2005121344","volume":"17","author":"C Zoccali","year":"2006","unstructured":"Zoccali C (2006) Endothelial dysfunction and the kidney: emerging risk factors for renal insufficiency and cardiovascular outcomes in essential hypertension. J Am Soc Nephrol 17(4 Suppl 2):S61\u2013S63","journal-title":"J Am Soc Nephrol"},{"issue":"3\u20134","key":"1993_CR18","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1159\/000351042","volume":"122","author":"X Zhe","year":"2012","unstructured":"Zhe X et al (2012) Hypertriglyceridemic waist is associated with increased carotid atherosclerosis in chronic kidney disease patients. Nephron Clin Pract 122(3\u20134):146\u2013152","journal-title":"Nephron Clin Pract"},{"issue":"3","key":"1993_CR19","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1097\/01.ASN.0000111744.00916.E6","volume":"15","author":"GA Kaysen","year":"2004","unstructured":"Kaysen GA, Eiserich JP (2004) The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction. J Am Soc Nephrol 15(3):538\u2013548","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1993_CR20","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1159\/000117813","volume":"28","author":"XW Zhe","year":"2008","unstructured":"Zhe XW et al (2008) Pulse wave velocity is associated with metabolic syndrome components in CAPD patients. Am J Nephrol 28(4):641\u2013646","journal-title":"Am J Nephrol"},{"issue":"6","key":"1993_CR21","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s11255-013-0431-1","volume":"45","author":"Y Bai","year":"2013","unstructured":"Bai Y et al (2013) Increased night heart rate is associated with worse large artery elasticity in chronic kidney disease patients. Int Urol Nephrol 45(6):1621\u20131627","journal-title":"Int Urol Nephrol"},{"issue":"1","key":"1993_CR22","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s00392-016-1024-7","volume":"106","author":"F Mangiacapra","year":"2017","unstructured":"Mangiacapra F et al (2017) Heart rate reduction by IVabradine for improvement of ENDothELial function in patients with coronary artery disease: the RIVENDEL study. Clin Res Cardiol 106(1):69\u201375","journal-title":"Clin Res Cardiol"},{"key":"1993_CR23","doi-asserted-by":"publisher","first-page":"705027","DOI":"10.1155\/2013\/705027","volume":"2013","author":"M Delehedde","year":"2013","unstructured":"Delehedde M et al (2013) Endocan in cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol 2013:705027","journal-title":"Int J Cell Biol"},{"issue":"5","key":"1993_CR24","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.3892\/or.2012.2012","volume":"28","author":"JH Kim","year":"2012","unstructured":"Kim JH et al (2012) Expression of endothelial cell-specific molecule-1 regulated by hypoxia inducible factor-1alpha in human colon carcinoma: impact of ESM-1 on prognosis and its correlation with clinicopathological features. Oncol Rep 28(5):1701\u20131708","journal-title":"Oncol Rep"},{"issue":"2","key":"1993_CR25","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1097\/01.CCM.0000198525.82124.74","volume":"34","author":"A Scherpereel","year":"2006","unstructured":"Scherpereel A et al (2006) Endocan, a new endothelial marker in human sepsis. Crit Care Med 34(2):532\u2013537","journal-title":"Crit Care Med"},{"issue":"3","key":"1993_CR26","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3109\/10520295.2011.577754","volume":"87","author":"SM Zhang","year":"2012","unstructured":"Zhang SM et al (2012) Expression and distribution of endocan in human tissues. Biotech Histochem 87(3):172\u2013178","journal-title":"Biotech Histochem"},{"issue":"1","key":"1993_CR27","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2015.09.030","volume":"243","author":"S Balta","year":"2015","unstructured":"Balta S et al (2015) Endocan: a novel inflammatory indicator in cardiovascular disease? Atherosclerosis 243(1):339\u2013343","journal-title":"Atherosclerosis"},{"issue":"5","key":"1993_CR28","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1111\/bjd.12525","volume":"169","author":"I Balta","year":"2013","unstructured":"Balta I et al (2013) Elevated serum levels of endocan in patients with psoriasis vulgaris: correlations with cardiovascular risk and activity of disease. Br J Dermatol 169(5):1066\u20131070","journal-title":"Br J Dermatol"},{"issue":"2","key":"1993_CR29","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.jaad.2013.09.013","volume":"70","author":"I Balta","year":"2014","unstructured":"Balta I et al (2014) Serum endocan levels as a marker of disease activity in patients with Behcet disease. J Am Acad Dermatol 70(2):291\u2013296","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"1993_CR30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1177\/0003319715591332","volume":"67","author":"S Balta","year":"2016","unstructured":"Balta S, Ozturk C (2016) Endocan, obstructive sleep apnea, and vascular risk. Angiology 67(4):305\u2013306","journal-title":"Angiology"},{"key":"1993_CR31","doi-asserted-by":"publisher","first-page":"2180765","DOI":"10.1155\/2016\/2180765","volume":"2016","author":"LC de Souza","year":"2016","unstructured":"de Souza LC et al (2016) Serum endocan levels associated with hypertension and loss of renal function in pediatric patients after two years from renal transplant. Int J Nephrol 2016:2180765","journal-title":"Int J Nephrol"},{"issue":"5","key":"1993_CR32","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1007\/s11255-015-0937-9","volume":"47","author":"J Rysz","year":"2015","unstructured":"Rysz J et al (2015) Should we use statins in all patients with chronic kidney disease without dialysis therapy? The current state of knowledge. Int Urol Nephrol 47(5):805\u2013813","journal-title":"Int Urol Nephrol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-018-1993-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1993-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1993-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,30]],"date-time":"2020-04-30T17:08:14Z","timestamp":1588266494000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-018-1993-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,1]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["1993"],"URL":"https:\/\/doi.org\/10.1007\/s11255-018-1993-8","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,1]]},"assertion":[{"value":"6 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None of the authors declare any conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments of comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}